Healthcare provider profile · identity verified

Peter Charles Smith, MD

Internal Medicine · LOVELAND, CO · NPI 1366425142

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	922	238
Atorvastatin Calcium	Atorvastatin Calcium	689	189
Amlodipine Besylate	Amlodipine Besylate	594	165
Rosuvastatin Calcium	Rosuvastatin Calcium	543	154
Losartan Potassium	Losartan Potassium	466	127
Omeprazole	Omeprazole	298	79
Lisinopril	Lisinopril	283	81
Metformin Hcl	Metformin Hcl	260	76
Tamsulosin Hcl	Tamsulosin Hcl	257	82
Potassium Chloride	Potassium Chloride	242	68
Gabapentin	Gabapentin	209	69
Allopurinol	Allopurinol	198	56
Eliquis	Apixaban	190	58
Furosemide	Furosemide	184	57
Simvastatin	Simvastatin	182	47
Zolpidem Tartrate	Zolpidem Tartrate	172	51
Escitalopram Oxalate	Escitalopram Oxalate	170	51
Metoprolol Tartrate	Metoprolol Tartrate	168	50
Carvedilol	Carvedilol	164	41
Alprazolam	Alprazolam	159	35
Pantoprazole Sodium	Pantoprazole Sodium	159	46
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	158	38
Trazodone Hcl	Trazodone Hcl	154	43
Metoprolol Succinate	Metoprolol Succinate	148	42
Telmisartan	Telmisartan	137	46
Oxycodone Hcl	Oxycodone Hcl	136	22
Finasteride	Finasteride	133	36
Tramadol Hcl	Tramadol Hcl	129	31
Lorazepam	Lorazepam	117	26
Montelukast Sodium	Montelukast Sodium	112	34
Synthroid	Levothyroxine Sodium	108	32
Prednisone	Prednisone	107	50
Clopidogrel	Clopidogrel Bisulfate	104	30
Hydrochlorothiazide	Hydrochlorothiazide	103	33
Spironolactone	Spironolactone	97	34
Duloxetine Hcl	Duloxetine Hcl	94	28
Bupropion Xl	Bupropion Hcl	93	23
Warfarin Sodium	Warfarin Sodium	87	25
Ozempic	Semaglutide	82	19
Donepezil Hcl	Donepezil Hcl	81	26
Albuterol Sulfate Hfa	Albuterol Sulfate	74	29
Cefuroxime	Cefuroxime Axetil	74	34
Olmesartan Medoxomil	Olmesartan Medoxomil	73	20
Sertraline Hcl	Sertraline Hcl	73	20
Tizanidine Hcl	Tizanidine Hcl	71	21
Citalopram Hbr	Citalopram Hydrobromide	68	15
Pregabalin	Pregabalin	68	20
Jardiance	Empagliflozin	67	18
Clonazepam	Clonazepam	64	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	62	20
Triamcinolone Acetonide	Triamcinolone Acetonide	62	36
Ramipril	Ramipril	61	19
Estradiol	Estradiol	60	24
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	57	11
Alendronate Sodium	Alendronate Sodium	56	15
Chlorthalidone	Chlorthalidone	56	21
Famotidine	Famotidine	55	15
Glimepiride	Glimepiride	55	16
Venlafaxine Hcl Er	Venlafaxine Hcl	55	12
Xarelto	Rivaroxaban	55	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	15
Pravastatin Sodium	Pravastatin Sodium	53	14
Metformin Hcl Er	Metformin Hcl	50	17
Oxybutynin Chloride	Oxybutynin Chloride	49	14
Topiramate	Topiramate	49	15
Amitriptyline Hcl	Amitriptyline Hcl	48	14
Azithromycin	Azithromycin	48	37
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	48	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	47	12
Meloxicam	Meloxicam	46	19
Eszopiclone	Eszopiclone	45	suppressed
Benazepril Hcl	Benazepril Hcl	39	11
Diazepam	Diazepam	38	12
Ezetimibe	Ezetimibe	38	13
Paroxetine Hcl	Paroxetine Hcl	38	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	11
Oxybutynin Chloride Er	Oxybutynin Chloride	34	13
Temazepam	Temazepam	34	suppressed
Memantine Hcl	Memantine Hcl	30	suppressed
Atenolol	Atenolol	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Fluticasone Propionate	Fluticasone Propionate	28	11
Methylphenidate Hcl	Methylphenidate Hcl	28	suppressed
Azelastine Hcl	Azelastine Hcl	27	20
Bumetanide	Bumetanide	27	12
Lovastatin	Lovastatin	27	suppressed
Myrbetriq	Mirabegron	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Cephalexin	Cephalexin	25	20
Divalproex Sodium	Divalproex Sodium	25	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	25	24
Mounjaro	Tirzepatide	24	suppressed
Celecoxib	Celecoxib	23	suppressed
Colchicine	Colchicine	23	12
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Valsartan	Valsartan	23	suppressed
Amoxicillin	Amoxicillin	22	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	17
Carbidopa-Levodopa	Carbidopa/Levodopa	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Minoxidil	Minoxidil	22	suppressed
Nystatin	Nystatin	22	14
Propranolol Hcl Er	Propranolol Hcl	22	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	21	suppressed
Glipizide Er	Glipizide	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Glipizide	Glipizide	20	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Olanzapine	Olanzapine	19	suppressed
Testosterone Cypionate	Testosterone Cypionate	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	14
Irbesartan	Irbesartan	18	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Rybelsus	Semaglutide	18	suppressed
Baclofen	Baclofen	17	suppressed
Cholestyramine	Cholestyramine (With Sugar)	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Dutasteride	Dutasteride	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Budesonide Dr	Budesonide	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Prolia	Denosumab	15	11
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Felbamate	Felbamate	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Famciclovir	Famciclovir	12	suppressed
Jantoven	Warfarin Sodium	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Primidone	Primidone	12	suppressed
Digoxin	Digoxin	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Rivastigmine	Rivastigmine	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error